# Healthcare AI Digest â€” 2025-12-31

**Articles:** 5 | **Generated:** 13:24

---


## AI

### ðŸŸ¢ Cleveland Clinic and G42 to Advance Healthcare through Artificial Intelligence - Cleveland Clinic Newsroom
**Cleveland Clinic Newsroom** | Score: 9/10

Cleveland Clinic and G42 are partnering to advance AI in healthcare, signaling significant strategic investment and validation of AI technologies in clinical and operational settings.

[Read more](https://news.google.com/rss/articles/CBMixAFBVV95cUxPcWZGSGNoX0x2RjFuWTd3VldMU3NKb05VdWd2eWI4Ql9kclloaktEcnBNbklhYlBBdjBMQUllN3p3VzVkWGkyUVF3UTQtV0ptUWtiNERCUVZYTTJvaTJIOUN4MGRNWUFmRHg2eXVzVjM2MkdrTEdidUVJYU9MbDF2WG9tbDB4VVZfSDktNkJMazlXREMyck9nRFdWYnpjWVQ4aTFoS3BsN2N0MDA3N0lETlZIZjYtM2dvckdfbWxwZ3lhcHRY?oc=5&hl=en-US&gl=US&ceid=US:en)

### ðŸŸ¢ A three-tier AI solution for equitable glaucoma diagnosis across Chinaâ€™s hierarchical healthcare system - Nature
**Nature** | Score: 8/10

A novel AI diagnostic solution for glaucoma targeting tiered healthcare systems demonstrates advanced clinical AI application in improving diagnostic accessibility and efficiency across resource-constrained medical environments.

[Read more](https://news.google.com/rss/articles/CBMiX0FVX3lxTE1IZlF4dVFOZ3BWOEhBdGhoOUtpbW1jUTZUNXdKVHI3YTl6U0pKRFRlX05zbFQyTEZHRnhGeEFNTnZsTkdvTnhQWTdETkVPdkpNQnZtd1ZRRVY5bVh0bkRJ?oc=5&hl=en-US&gl=US&ceid=US:en)


## Digital Health|Funding

### âšª 4 Notable Health Tech Funding Announcements in December - MedCity News
**MedCity News** | Score: 7/10

Article highlights four notable digital health funding rounds in December, providing insights into investment trends and emerging health technology companies.

[Read more](https://news.google.com/rss/articles/CBMikgFBVV95cUxPaDNMZTN4RFdWNWNxUnBvQ2w0ODE3NWZlLUdZVTdoTDctVnJQUXFGQnR2b3lrZHZHU3NCTlVmVFlQc2lDUFJfd0tVbUJlSmVONHVwUDZ4VVVtWjdLQWx5WVlXSUtGcUlOR1lJQ2pjclg3TG9kRVk4NWhMOUZrdVZUNXRFUHExTHBwRTVBSmR4bHlNQQ?oc=5&hl=en-US&gl=US&ceid=US:en)


## GLP-1

### ðŸŸ¢ Lilly and Novo Cut GLP-1 Prices as Pill Approvals Expand Access - Yahoo Finance
**Yahoo Finance** | Score: 9/10

Major pharmaceutical companies Lilly and Novo Nordisk are strategically reducing GLP-1 medication prices to expand market access, potentially accelerating obesity treatment market growth and adoption.

[Read more](https://news.google.com/rss/articles/CBMidEFVX3lxTE5ZazdnWG8wNW9BR1pYdHl1X29xNlNxZldWZEZ5VlJfSlM1dlpxMks0R0hWQVF3WTdtQzY5UFhTYi0ySWdsdGR1T29GU0lwMEpVN1R1VnNraVJuUENZRU4zVWUwSExGWjhvT1Bvem5wSmxWRFd1?oc=5&hl=en-US&gl=US&ceid=US:en)

### ðŸŸ¢ 2 Companies Poised to Capitalize on the Rise of GLP-1 Weight Loss Drugs - Morningstar Canada
**Morningstar Canada** | Score: 8/10

Article discusses market opportunities for companies benefiting from the rising GLP-1 weight loss drug market, highlighting potential investment perspectives on emerging pharmaceutical trends.

[Read more](https://news.google.com/rss/articles/CBMiqAFBVV95cUxQR183amFVeTF1SWFIMnVYdWFfWFhCNU5iZUpndjVPaGkwaFY4LXIyQ3IwNmpuWC1PYk9iZmVHMGplX28tM3B2VWoxTFNlMkZMRlBaWTdFWGVKcGlZNEhRNnhKRWt1Ri1SR2o2UWtfbDF1Z2dDM1Uwb0wzSjdmWjEtb3BwMFUyM3hQVFd2UVlwcVFoQlJhWm5KMHJHZkNFakoydVItU0xBMEg?oc=5&hl=en-US&gl=US&ceid=US:en)


---
#daily-digest #healthcare-ai
